A Survey of the Effectiveness of Prothrombin Complex Concentrates in Controlling Hemorrhage in Patients with Hemophilia and Anti-Factor VIII Antibodies

Summary

The treatment of patients with hemophilia A and anti-Factor VIII antibodies is difficult. Between July 1977 and June 1978, a survey was carried out by an ad hoc working party of the subcommittee on Factor IX concentrates of the International Committee on Thrombosis and Hemostasis to assess the effectiveness of Prothrombin Complex Concentrates in controlling hemorrhage in these patients. The results are presented in this paper and, although subjective, support the view that these concentrates are not as effective in patients with inhibitors as Factor VIII concentrates are in patients without inhibitors.

• References

• 1 White GC, Lundblad RL, and Kingdon HS. Prothrombin Complex Concentrates: Preparation, Properties, and Clinical Uses. Current Topics in Hematology 1979; 2: 203-244
• 2 Penner JA, Abildgaard CF. Ineffectivenes of certain commercial prothrombin concentrates in the treatment of patients with inhibitors of factor VIII and IX. (Letter) NEJM 1979; 300: 565-566
• 3 Blatt PM, Pearsall AH, Givhan EG, Hallum CE, Roberts HR, Webster WP. Haemostatic Failure of Prothrombin Complex Concentrates During Elective Dental Procedure. Thromb Haemostas, 1980; 42: 1604-1606